Company · CIK 1673772
RAPT Therapeutics, Inc.
| CIK | 1673772 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-12-11 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-273910 | 2023-08-11 | 2026-03-04 | 6 | |
| 333-284388 | 2025-01-21 | 2026-03-04 | 3 | |
| 333-249848 | 2020-11-04 | 2022-11-18 | 6 | |
| 333-265812 | 2022-06-24 | 2022-06-29 | 2 | |
| 333-236256 | 2020-02-04 | 2020-02-07 | 3 | |
| 333-232572 | 2019-07-05 | 2019-11-01 | 7 |
Filings
29| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-04 | EFFECTDeclared effective | 333-284388 | 9999999995-26-000719 |
| 2026-03-04 | EFFECTDeclared effective | 333-273910 | 9999999995-26-000717 |
| 2025-10-22 | 424B5Shelf takedown | 333-273910 | 0001193125-25-246928 |
| 2025-10-21 | 424B5Shelf takedown | 333-273910 | 0001193125-25-245097 |
| 2025-01-27 | EFFECTDeclared effective | 333-284388 | 9999999995-25-000211 |
| 2025-01-21 | S-3Shelf registered | 333-284388 | 0001193125-25-009605 |
| 2023-08-18 | 424B5Shelf takedown | 333-273910 | 0001193125-23-215157 |
| 2023-08-17 | EFFECTDeclared effective | 333-273910 | 9999999995-23-002435 |
| 2023-08-11 | S-3Shelf registered | 333-273910 | 0001193125-23-209920 |
| 2022-11-18 | 424B5Shelf takedown | 333-249848 | 0001193125-22-289085 |
| 2022-11-17 | 424B5Shelf takedown | 333-249848 | 0001193125-22-287809 |
| 2022-06-29 | EFFECTDeclared effective | 333-265812 | 9999999995-22-001928 |
| 2022-06-24 | S-3Shelf registered | 333-265812 | 0001193125-22-180817 |
| 2021-06-16 | 424B5Shelf takedown | 333-249848 | 0001193125-21-192158 |
| 2021-06-14 | 424B5Shelf takedown | 333-249848 | 0001193125-21-190017 |
| 2020-11-16 | EFFECTDeclared effective | 333-249848 | 9999999995-20-003189 |
| 2020-11-04 | S-3Shelf registered | 333-249848 | 0001193125-20-285582 |
| 2020-02-07 | 424B4Final prospectus | 333-236256 | 0001193125-20-028186 |
| 2020-02-06 | EFFECTDeclared effective | 333-236256 | 9999999995-20-000284 |
| 2020-02-04 | S-1Registration filed | 333-236256 | 0001193125-20-024342 |
| 2020-01-28 | DRSDraft made public | 377-03018 | 0000950123-20-000570 |
| 2019-11-01 | 424B4Final prospectus | 333-232572 | 0001193125-19-280872 |
| 2019-10-30 | EFFECTDeclared effective | 333-232572 | 9999999995-19-002425 |
| 2019-10-28 | S-1/AAmendment | 333-232572 | 0001193125-19-275397 |
| 2019-10-22 | S-1/AAmendment | 333-232572 | 0001193125-19-271052 |
| 2019-07-24 | S-1/AAmendment | 333-232572 | 0001193125-19-201355 |
| 2019-07-22 | S-1/AAmendment | 333-232572 | 0001193125-19-198410 |
| 2019-07-05 | S-1Registration filed | 333-232572 | 0001193125-19-189775 |
| 2019-05-24 | DRSDraft made public | 377-02668 | 0000950123-19-005696 |